SCHEMBL30385115

SCHEMBL30385115

COc1cc(N2CCOCC2)c([N+](=O)[O-])cc1Nc1ncc(F)c(-n2cc(C)c(C=O)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 4/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LRRK2 Q5S007 10/20 0.39
GSK3A P49840 1/20 0.39
MAPK15 Q8TD08 1/20 0.39
CAMKK2 Q96RR4 1/20 0.39
DCLK1 O15075 1/20 0.38
MAPK7 Q13164 1/20 0.38
S1PR1 P21453 1/20 0.37
INSR P06213 1/20 0.37
ALK Q9UM73 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17670333 1.00 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL30384722 0.93 LRRK2 (0.39) SMN1; SMN2MAPTALDH1A1LRRK2DCLK1
SCHEMBL17670207 0.93 LRRK2 (0.39) SMN1; SMN2MAPTALDH1A1LRRK2DCLK1
SCHEMBL17670158 0.93 PTK2 (0.39) MAPTALDH1A1LRRK2MAPK7ALK
SCHEMBL30384375 0.88 GAA (0.41) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL17670245 0.88 GAA (0.41) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL30384778 0.87 EGFR (0.39) SMN1; SMN2NPC1RAB9AGAALRRK2
SCHEMBL17670221 0.87 EGFR (0.39) SMN1; SMN2NPC1RAB9AGAALRRK2
SCHEMBL17670453 0.83 EGFR (0.37) MAPTALDH1A1LMNALRRK2ALK
SCHEMBL17670459 0.83 EGFR (0.42) MAPTALDH1A1LRRK2ALKCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111686110-B Compounds and compositions for modulating EGFR mutant kinase activity 株式会社柳韩洋行 2023-06-16 CN disclosed